Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
about
The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysisData-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells.Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells.Functional studies on circulating and disseminated tumor cells in carcinoma patientsGene expression profiling and DNA methylation analyses of CTCs.Clinical and biological significance of circulating tumor cells in cancer.Epithelial-mesenchymal plasticity in circulating tumor cells.Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal TransitionMINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment.Urothelial cancer proteomics provides both prognostic and functional information.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Serum irisin associates with breast cancer to spinal metastasis.
P2860
Q26752303-204AEB10-DAA7-4059-AFCA-FAD3AC638D3AQ31171102-D82F9E52-7975-43AB-96E3-84595EDB3D49Q36018511-96BDF526-D7B9-4E20-AB5F-1C399F245537Q36388852-915C9E04-832A-40B2-8BD6-2C9F1DA8BA9DQ38723767-6E70C971-66F4-4FE9-8B7D-CD0DBD7924A0Q38734877-2302C7E1-7701-4C62-8AC2-F339D57233F9Q38743200-10FB8732-5D28-41DB-86C6-F09CFD559EB3Q39053335-980C22A5-092A-4774-8E82-82DE4B361B37Q39339880-E16B08AE-E10F-4DAF-8A49-23EDCF72D233Q39612538-D8D927C0-D0C2-496C-960F-A3220BA46124Q41661081-63F239E8-E692-454C-BC2E-1F36D982027FQ41684073-B188C8D2-BB1A-4300-8B21-A47D085A9038Q41822137-8047D464-89CC-4F77-8336-F3026690BEEDQ47156880-F2020EE4-0F8F-47F5-A52C-C6DC0B6FA430Q50199981-111A5515-8451-4E84-8B49-11D7AF85682FQ55034997-8409271B-F4B7-401F-B6FC-1C54B9E8AE35
P2860
Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating tumour cell-derive ...... n patients with breast cancer.
@ast
Circulating tumour cell-derive ...... n patients with breast cancer.
@en
type
label
Circulating tumour cell-derive ...... n patients with breast cancer.
@ast
Circulating tumour cell-derive ...... n patients with breast cancer.
@en
prefLabel
Circulating tumour cell-derive ...... n patients with breast cancer.
@ast
Circulating tumour cell-derive ...... n patients with breast cancer.
@en
P2093
P2860
P356
P1476
Circulating tumour cell-derive ...... n patients with breast cancer.
@en
P2093
K Bartkowiak
K Sugimachi
T M Gorges
P2860
P2888
P304
P356
10.1038/BJC.2015.132
P407
P577
2015-04-16T00:00:00Z